Cargando…
Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
Autor principal: | Tangpricha, Vin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113784/ https://www.ncbi.nlm.nih.gov/pubmed/35106582 http://dx.doi.org/10.1210/clinem/dgac060 |
Ejemplares similares
-
Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
por: van Velzen, Daan, et al.
Publicado: (2021) -
Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy
por: Hashemi, Leila, et al.
Publicado: (2021) -
Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study
por: Suppakitjanusant, Pichatorn, et al.
Publicado: (2020) -
Correction of the Gene Defect in Cystic Fibrosis: Is It Too Late for Bone?
por: Tangpricha, Vin
Publicado: (2021) -
Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)